<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Home</title>
	<atom:link href="http://cptrinitiative.org/home/feed/" rel="self" type="application/rss+xml" />
	<link>http://cptrinitiative.org</link>
	<description>A new paradigm for TB drug development is needed—one that focuses on developing not just drugs but entire drug regimens.</description>
	<lastBuildDate>Thu, 10 Jan 2013 15:31:58 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
	<item>
		<title>By: Working Group on New TB Drugs</title>
		<link>http://cptrinitiative.org/#comment-2</link>
		<dc:creator>Working Group on New TB Drugs</dc:creator>
		<pubDate>Mon, 08 Nov 2010 13:13:07 +0000</pubDate>
		<guid isPermaLink="false">http://cptrinitiative.org/#comment-2</guid>
		<description>[...] is being tested under a research platform championed by the Critical Path to TB Drug Regimens (CPTR) initiative that has the potential to shorten the time needed to develop novel TB regimens by as much as 75% by [...]</description>
		<content:encoded><![CDATA[<p>[...] is being tested under a research platform championed by the Critical Path to TB Drug Regimens (CPTR) initiative that has the potential to shorten the time needed to develop novel TB regimens by as much as 75% by [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
